Healthcare Royalty, Inc. Business Finance Contracts & Agreements
8 Contracts & Agreements
- Exchange Agreements (1 contract)
- Purchase Agreements (4)
- Registration Rights Agreements (1)
- Stock Agreements (1)
- Underwriting Agreements (1)
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 29, 2021)
- Form of Class A Common Stock Certificate (Filed With SEC on July 29, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 29, 2021)
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 1, 2021)
- Purchase and Sale Agreement, dated as of February 2, 2017, by and between Portola Pharmaceuticals and Entities Managed by Healthcare Royalty Management, LLC (Filed With SEC on July 1, 2021)
- Asset Purchase Agreement, dated July 7, 2020, between Harris FRC Acquisition, LP and Harris FRC Corporation (Filed With SEC on July 1, 2021)
- Form of Exchange Agreement (Filed With SEC on July 1, 2021)
- Form of Registration Rights Agreement (Filed With SEC on July 1, 2021)
